Follow
Ross W Ward
Ross W Ward
Other namesRoss William Ward
Postdoctoral Researcher, Icahn School of Medicine at Mount Sinai
Verified email at tcd.ie
Title
Cited by
Cited by
Year
Mucosal vaccines—fortifying the frontiers
EC Lavelle, RW Ward
Nature Reviews Immunology 22 (4), 236-250, 2022
4452022
Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles
N Muñoz-Wolf, RW Ward, CH Hearnden, FA Sharp, J Geoghegan, ...
Cell Reports Medicine 4 (1), 2023
182023
Publisher Correction: Mucosal vaccines—fortifying the frontiers
EC Lavelle, RW Ward
Nature reviews. Immunology 22 (4), 266, 2022
132022
Myeloid cell–derived proteases produce a proinflammatory form of IL-37 that signals via IL-36 receptor engagement
GP Sullivan, P Davidovich, N Muñoz-Wolf, RW Ward, ...
Science Immunology 7 (78), eade5728, 2022
52022
Protocol for the development of mRNA lipid nanoparticle vaccines and analysis of immunization efficiency in mice
N Karekar, AR Cahn, J Morla-Folch, A Saffon, RW Ward, ...
STAR protocols 5 (2), 103087, 2024
2024
Intratumoral delivery of the chitin-derived C100 adjuvant promotes robust STING, IFNAR, and CD8+ T cell-dependent anti-tumor immunity
JL Turley, RW Ward, J Huete-Carrasco, N Muñoz-Wolf, K Roche, L Jin, ...
Cell Reports Medicine 5 (5), 2024
2024
Immunotherapy for cancer
E Lavelle, J Turley, R Ward
US Patent App. 18/039,107, 2024
2024
Rational design of polymer‐based particulate vaccine adjuvants
J Huete‐Carrasco, RI Lynch, RW Ward, EC Lavelle
European Journal of Immunology 54 (2), 2350512, 2024
2024
F-02 Inflammasome activating nanoparticles promote protective anti-tumour CD8 (+) T cells
R Ward, N Munoz-Wolf, EC Lavelle
yEFIS 1st Symposium: Shaping the future of Immunology in Europe 52, 25-25, 2022
2022
O-01 Enhancing antigen cross-presentation and CD8 (+) T cell responses by adsorbing antigen to nanoparticles
J Huete-Carrasco, N Munoz-Wolf, RW Ward, EC Lavelle
yEFIS 1st Symposium: Shaping the future of Immunology in Europe 52, 4-4, 2022
2022
P-1013 A novel polymer-based STING activator with potent anti-tumour activity
JL Turley, R W Ward, M Andersson, EC Lavelle
6th European Congress of Immunology 51, 396-396, 2021
2021
P-0842 Small polymeric nanoparticles drive potent anti‐tumour immunity
R William Ward, N Munoz-Wolf, E C Lavelle
6th European Congress of Immunology 51, 1-448, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–12